---
document_datetime: 2023-09-21 19:47:20
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/imatinib-medac-epar-all-authorised-presentations_en.pdf
document_name: imatinib-medac-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7259859
conversion_datetime: 2025-12-28 12:50:30.454173
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA(EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging       | Pack size   |
|-----------------|-------------------|------------|-----------------------|---------------------------|---------------------------|-------------|
| EU/1/13/876/001 | Imatinib medac    | 100 mg     | Capsule, hard         | Oral use                  | blister (PA- alu/PVC/alu) | 60 capsules |
| EU/1/13/876/002 | Imatinib medac    | 400 mg     | Capsule, hard         | Oral use                  | blister (PA-              | 30 capsules |

<!-- image -->